Universus Photo Imagings Limited (NSE: UNIVPHOTO | BSE: 542933)
Source: Universus Photo Imagings Limited Annual Report FY 2025-26 (Fiscal Year Ended March 31, 2026)
📋 Quick Facts: Company Snapshot
| Attribute | Disclosed Detail |
|---|---|
| Official Company Name | Universus Photo Imagings Limited |
| Corporate Identity Number (CIN) | L22222UP2011PLC103611 |
| ISIN | INE03V001013 |
| NSE Symbol & BSE Scrip Code | NSE: UNIVPHOTO | BSE: 542933 |
| Date of Incorporation / Founding Year | November 2011 (Demerged effective April 1, 2019) |
| Registered Office | 19th K.M. Hapur-Bulandshahr Road, P.O. Gulaothi, Distt. Bulandshahr, Uttar Pradesh – 245408 |
| Corporate Headquarters | Plot No. 12, Sector B-1, Local Shopping Complex, Vasant Kunj, New Delhi – 110070 |
| Telephone & Investor Relations Contact | Tel: +91-011-40322100 | Email: cs_uphoto@universusphotoimagings.com |
| Chairman | Mr. Sanjeev Aggarwal (Chairman & Independent Director) |
| Managing Director & CEO | Mr. Shailendra Sinha (Managing Director) |
| Chief Financial Officer (CFO) | Mr. Naveen Chandra Barthwal |
| Company Secretary & Compliance Officer | Mr. Suresh Kumar (ACS 41503) |
| Promoter & Holding Group | B.C. Jindal Group (Immediate Parent: Concatenate Imaging Advest Private Limited) |
| Industry / Sector Classification | Photographic Products & Medical Consumables / Flexible Poly Films Conversion |
| Total Permanent Employees | 38 permanent employees (as of March 31, 2026) |
| Manufacturing Plants Count | 1 conversion and processing plant (Dadra, Dadra & Nagar Haveli) |
| Statutory Auditors | M/s Suresh Kumar Mittal & Co., Chartered Accountants (FRN: 500063N) |
| Secretarial Auditors | M/s DMK Associates, Practicing Company Secretaries |
| Registrar and Share Transfer Agent (RTA) | KFin Technologies Limited, Hyderabad |
🏢 The Corporate Identity: Universus Photo Imagings Overview, Promoters & History
The Big Picture: Business Model & Core Value Proposition
Universus Photo Imagings Limited operates within the specialized diagnostic imaging and photographic materials processing sector in India. The enterprise acts as an operational conversion, distribution, and slitting hub for medical imaging solutions and specialty films. Its primary operational model centers on the procurement of master rolls—specifically jumbo rolls of conventional medical X-ray films and non-tearable (NTR) films—which are subsequently precision-slit, converted, packaged, and distributed under controlled darkroom environments to meet standard diagnostic and specialty printing specifications.
The company’s strategic proposition lies in supplying cost-effective, analog diagnostic consumables to underserved tiers of healthcare infrastructure where digital radiography infrastructure remains constrained by capital outlays and power unreliability. By bridging the clinical demand across rural medical centers, semi-urban nursing homes, state government healthcare tenders, and select international emerging markets, Universus sustains cash flows from a legacy asset base while maintaining a liquid treasury portfolio.
The Founders, Promoters & Their Legacy
Universus Photo Imagings Limited trace its industrial heritage to the B.C. Jindal Group, an Indian manufacturing conglomerate established in 1952 with core operational track records across flexible packaging, polyester films, steel pipes, and power generation. The group’s promoter framework within the company operates through principal holding entities including Concatenate Imaging Advest Private Limited, Consolidated Finvest & Holdings Limited, and promoter trusts established for the Jindal family lineage.
Promoter entities exercise controlling oversight over the company, maintaining a 74.55% aggregate equity holding as of March 31, 2026. The governance structure leverages family trusts, notably the Bhavesh Trust and Futuristic Trust (formerly SSJ Trust), ensuring alignment between institutional ownership, operational capital allocation, and group treasury mandates across diversified downstream processing initiatives.
The Journey: Corporate History & Key Milestones
The enterprise was formally incorporated under the Companies Act in November 2011 under the name Jindal Photo Imaging Limited. Prior to fiscal year 2019, the corporate entity remained dormant without active commercial manufacturing operations. The transformation into an active public operating entity was initiated through a composite scheme of arrangement and demerger sanctioned by corporate regulatory frameworks.
- November 2011: Corporate incorporation as Jindal Photo Imaging Limited in Uttar Pradesh.
- April 1, 2019: The Photo Films business of Jindal Poly Films Limited was demerged into the company pursuant to a composite Scheme of Arrangement, transferring manufacturing assets, customer contracts, and associated undertakings.
- Demerger Transition: Rebranded to Universus Photo Imagings Limited to establish an independent diagnostic consumables footprint and facilitate public listing on the National Stock Exchange of India and BSE Limited.
- March 2026: Expanded equity exposure in foreign associate JPF Netherlands B.V. via proportional rights subscription amounting to ₹1.25 Crore (₹1.25 Crores).
The Corporate Umbrella & Group Structure
Universus Photo Imagings Limited sits as a specialized processing and holding associate within the broader B.C. Jindal industrial perimeter. While operating as an independent listed corporate vehicle, it shares operational synergies, related-party supply arrangements, and co-investment frameworks with allied group entities including Jindal Poly Films Limited, JPFL Films Private Limited, and Universus Poly & Steel Limited. Its primary international corporate linkage is maintained through its 39.87% equity stake in JPF Netherlands B.V., which acts as an offshore holding umbrella for multinational flexible packaging assets spanning Europe, the Americas, and the Middle East.
⚙️ The Business Engine: Segments, Brands, Products & Operations
The Core Divisions & Segment Revenue Breakdown
In accordance with Ind AS 108 (Operating Segments), the company’s executive management monitors operations under a single primary reportable operating business segment: Photographic Products. This encompassing division encapsulates the slitting, converting, packaging, trading, and distribution of medical X-ray films, graphic art materials, and specialty photographic substrate sheets.
| Segment Classification | FY 2025-26 Revenue (₹ in Crores) | FY 2024-25 Revenue (₹ in Crores) | % Share of Total Operations | Segment Results / PAT (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|---|---|
| Photographic Products (Standalone Operations) | 1,877.66 | 2,459.60 | 100.00% | 1,925.91 | -23.66% |
| Share of Loss / Profit from Associate (JPF Netherlands B.V.) | – | – | – | (99.20) | – |
| Total Consolidated Operations | 1,877.66 | 2,459.60 | 100.00% | (7,993.63) | -23.66% |
The Product & Service Catalog (with Operational KPIs)
The operational product portfolio is structured across two primary conversion lines: Diagnostic Radiology Consumables and Non-Tearable Substrates.
- Conventional Medical X-Ray Films: Wet analog imaging films utilized in chest radiography, orthopedic diagnostics, trauma screening, and general medical radiology. The company converts imported jumbo rolls into industry-standard clinical cut sheet dimensions under specialized temperature-controlled environments.
- Non-Tearable (NTR) Films: High-durability polyester-based substrate sheets coated for graphic applications, commercial photography, digital printing, certificates, durable ID cards, luxury wedding albums, restaurant menus, calendars, and modeling portfolios available in matte and glossy finishes.
- Trading Operations: Procurement and resale of complementary imaging accessories, chemicals, and finished substrate packages to institutional distributors.
- Installed Operational Capacity: The Dadra manufacturing plant houses precision slitting units with an aggregate installed conversion capacity of approximately 3,00,000 square meters per month.
- Domestic Addressable Market Size: The total Indian annual consumption market for conventional wet medical films is estimated at approximately 10 Lakh square meters per annum, facing sustained structural pressure from computerized and digital radiography migration.
The Names You Know: Key Brands & Flagship Portfolio
| Brand / Product Line | Category / Business Segment | Target Market & Key Positioning |
|---|---|---|
| Medical X-Ray Film Portfolio | Diagnostic Imaging Consumables | Tier II/III/IV clinics, government district hospitals, analog medical imaging centers requiring dependable, low-cost diagnostic film. |
| NTR Premium Substrates (Matte / Glossy) | Commercial Specialty Graphic Films | Photo labs, commercial digital printing presses, photo album binders, and corporate stationery printers requiring moisture-proof tear resistance. |
| Imaging Traded Supplies | Diagnostic Accessories & Specialty Films | Specialized diagnostic laboratories and regional radiology distributors across India and selected emerging export jurisdictions. |
Mapping the Domestic & Global Reach (India vs. Exports)
While the company directs the substantial majority of its finished roll conversions to the Indian domestic healthcare distribution channel, it maintains an active export pipeline targeting resource-constrained healthcare systems internationally.
| Geographic Market | FY 2025-26 Outflow / Inflow (₹ in Crores) | FY 2024-25 Outflow / Inflow (₹ in Crores) | Primary Operational Nature | Latest YoY (%) |
|---|---|---|---|---|
| Foreign Exchange Earnings (Direct Exports) | 2.40 | 3.58 | Export sales of converted X-ray films to developing markets (e.g., Africa) | -32.96% |
| Foreign Exchange Outgo (Direct Imports) | 6.77 | 13.07 | Import of jumbo raw material master rolls and photo film supplies | -48.20% |
| Net Foreign Exchange Balance | (4.37) | (9.48) | Net importer profile for specialized master photographic base stock | -53.90% |
The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices
Universus conducts its conversion activities through a centralized production hub supported by corporate oversight in the National Capital Region.
- Dadra Conversion Facility: Located at 260/23, Sheetal Industrial Estate, Demani Road, Dadra – 396193 (Union Territory of Dadra & Nagar Haveli and Daman & Diu). The facility holds quality certifications including ISO 9001:2015 (Quality Management System) and ISO 13485:2016 (Medical Device Quality Management System).
- Corporate Headquarters: Plot No. 12, Local Shopping Complex, Sector B-1, Vasant Kunj, New Delhi – 110070.
- Registered Office: 19th K.M. Hapur-Bulandshahr Road, P.O. Gulaothi, Distt. Bulandshahr, Uttar Pradesh – 245408.
📊 The Financial Health: The Numbers Simplified
The consolidated financial profile of Universus Photo Imagings Limited reflects the dual impact of stable, cash-generative domestic conversion operations and volatility introduced via equity accounting for its global associate company, JPF Netherlands B.V. On a standalone basis, the operating engine generated positive profit after tax of ₹19.26 Crores in FY 2025-26, supported by strong treasury yields. However, the consolidated statement under Ind AS 28 includes an equity loss of ₹99.20 Crores from the associate, resulting in a consolidated net loss of ₹79.94 Crores.
Earnings, Expenses, & Take-Home Profits (Consolidated Profit & Loss)
| Statement of Profit and Loss Line Item | FY 2025-26 (₹ in Crores) | FY 2024-25 (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|
| Revenue from Operations | 18.78 | 24.60 | -23.66% |
| Other Income | 20.94 | 42.23 | -50.41% |
| Total Revenue | 39.72 | 66.83 | -40.57% |
| Cost of Materials Consumed | 9.81 | 11.63 | -15.65% |
| Purchase of Stock-in-trade | 2.20 | 3.24 | -32.10% |
| Changes in Inventories of Finished goods, Work-in-Progress and Stock-in-Trade | 0.62 | 2.51 | -75.30% |
| Employee Benefits Expense | 2.89 | 3.75 | -22.93% |
| Finance Costs | 0.00 | 0.00 | N/M |
| Depreciation and Amortization Expense | 0.12 | 0.13 | -7.69% |
| Other Expenses | 3.54 | 5.22 | -32.18% |
| Total Expenses | 19.19 | 26.48 | -27.53% |
| Profit Before Share of Profit/(Loss) of Associates | 20.53 | 40.34 | -49.11% |
| Share of Profit/(Loss) of Associates | (99.20) | 55.27 | N/M |
| Profit / (Loss) Before Tax | (78.66) | 95.61 | N/M |
| Current Tax (including Earlier Year Tax) | 4.48 | 6.18 | -27.51% |
| Deferred Tax | (3.21) | 2.42 | N/M |
| Total Tax Expenses | 1.27 | 8.60 | -85.23% |
| Profit / (Loss) for the period (PAT) | -0.80 | 0.87 | N/M |
| Other Comprehensive Income (OCI) | |||
| Remeasurements of post employment benefit obligations | 0.13 | (0.04) | N/M |
| Share in OCI of Associates | (10.33) | 11.40 | N/M |
| Foreign Currency Translation Reserve | 73.16 | 7.29 | +903.57% |
| Total Other Comprehensive Income for the year | 62.96 | 18.65 | +237.59% |
| Total Comprehensive Income For the year | (16.98) | 105.67 | N/M |
| Basic Earnings per Equity Share (in ₹) | (73.02) | 79.49 | N/M |
| Diluted Earnings per Equity Share (in ₹) | (73.02) | 79.49 | N/M |
Assets, Borrowings, & Net Worth (Consolidated Balance Sheet)
| Consolidated Balance Sheet Line Item | As at 31st March 2026 (₹ in Crores) | As at 31st March 2025 (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|
| Non-Current Assets | |||
| Property, Plant and Equipment | 0.04 | 0.04 | 0.00% |
| Non-Current Financial Assets: Investments | 5.44 | 5.02 | +8.37% |
| Non-Current Financial Assets: Other Financial Assets | 0.00 | 0.00 | N/M |
| Total Non Current Assets | 5.49 | 5.06 | +8.50% |
| Current Assets | |||
| Inventories | 0.02 | 0.06 | -66.67% |
| Current Financial Assets: Investments | 2.73 | 3.77 | -27.59% |
| Current Financial Assets: Trade Receivables | 0.00 | 0.01 | -100.00% |
| Current Financial Assets: Cash and Cash Equivalents | 0.00 | 0.00 | N/M |
| Current Financial Assets: Other Financial Assets | 0.01 | 0.01 | 0.00% |
| Other Current Assets | 0.01 | 0.02 | -50.00% |
| Total Current Assets | 2.76 | 3.86 | -28.50% |
| Total Assets | 8.25 | 8.92 | -7.51% |
| Equity | |||
| Equity Share Capital | 0.11 | 0.11 | 0.00% |
| Other Equity | 8.00 | 8.63 | -7.30% |
| Total Equity (Net Worth) | 8.11 | 8.74 | -7.21% |
| Non-Current Liabilities | |||
| Non-Current Provisions | – | 0.00 | – |
| Deferred Tax Liabilities (Net) | 0.13 | 0.16 | -18.75% |
| Total Non Current Liabilities | 0.13 | 0.16 | -18.75% |
| Current Liabilities | |||
| Trade Payables – Micro Enterprises and Small Enterprises | 0.00 | 0.00 | N/M |
| Trade Payables – Other than Micro & Small Enterprises | 0.00 | 0.00 | N/M |
| Other Financial Liabilities | 0.00 | 0.01 | -100.00% |
| Other Current liabilities | 0.00 | 0.00 | N/M |
| Current Provisions | – | 0.00 | – |
| Current Tax Liabilities (Net) | 0.00 | 0.00 | N/M |
| Total Current Liabilities | 0.01 | 0.02 | -50.00% |
| Total Liabilities | 0.14 | 0.18 | -22.22% |
| Total Equity and Liabilities | 8.25 | 8.92 | -7.51% |
Cash Flow: Tracking the Money Movement
| Consolidated Cash Flow Statement Component | FY 2025-26 (₹ in Crores) | FY 2024-25 (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|
| A. Cash Inflow / (Outflow) From Operating Activities | |||
| Net Profit / (Loss) Before Tax | (78.66) | 95.61 | N/M |
| Other Comprehensive Income | 62.96 | 18.65 | +237.59% |
| Change in share in net worth of associate company | 36.37 | (73.39) | N/M |
| Depreciation and Amortisation | 0.12 | 0.13 | -7.69% |
| Amortisation of Deferred Government Grant | – | (0.93) | – |
| Net loss / (gain) on disposal/discard of property, plant and equipment | (0.01) | – | – |
| Gain on sale of Investment in Mutual Fund Units (net) | (23.55) | (12.63) | +86.46% |
| Fair Value Adjustments on Financial Assets (net) | 4.57 | (26.27) | N/M |
| Operating Profit before Working Capital Changes | 1.78 | 1.18 | +50.85% |
| Trade and Other Receivables | 2.01 | 188.19 | -98.93% |
| Inventories | 3.84 | 0.99 | +287.88% |
| Trade and Other Payables | (0.83) | 0.10 | N/M |
| Cash generated from Operations | 680.89 | 19,045.60 | -96.42% |
| Direct Tax Paid / TDS Deducted | (4.76) | (5.75) | -17.22% |
| Net cash generated from Operating Activities (A) | 2.05 | 184.71 | -98.89% |
| B. Cash Inflow / (Outflow) From Investing Activities | |||
| Purchase of Property, Plant & Equipments and Intangibles (CapEx) | (0.00) | (0.01) | -100.00% |
| Sales Proceeds of Property, Plant & Equipments | -249.15% | 453.26% | – |
| Purchase / Sale of Investments | (2.09) | (185.96) | -98.88% |
| Net Cash used in Investing Activities (B) | (2.06) | (185.96) | -98.89% |
| C. Cash Inflow / (Outflow) From Financing Activities | |||
| Finance Costs Paid | (0.00) | (0.00) | N/M |
| Net Cash used in Financing Activities (C) | (0.00) | (0.00) | N/M |
| Net Increase / (Decrease) in Cash and Cash Equivalents (A+B+C) | (0.00) | (1.26) | -100.00% |
| Opening Balance of Cash and Cash Equivalents | 0.13 | 1.39 | -90.65% |
| Closing Balance of Cash and Cash Equivalents | 0.13 | 0.13 | 0.00% |
Funding the Future: CapEx, CWIP & Treasury Allocations
Capital expenditure commitments on physical conversion infrastructure remained minimal during FY 2025-26, totaling ₹0.0009 Crores against ₹0.0055 Crores in FY 2024-25. The company’s core capital allocation was directed toward strategic treasury deployments. Surplus capital generated from operating cycles and prior portfolio redemptions was channeled into top-tier mutual fund debt securities (₹2.73 Crores held at fair value) and supporting associate equity requirements in JPF Netherlands B.V. (₹1.25 Crores right issue subscription).
👥 Power & Control: Corporate Governance, Leadership & Ownership
The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)
Universus Photo Imagings maintains a six-member Board of Directors comprising five Non-Executive Directors and one Executive Director. The Board composition complies with Regulation 17 of SEBI Listing Regulations, featuring an Independent Chairman, one Independent Woman Director, and three Non-Executive Directors representing promoter and professional disciplines.
| Name of Director / KMP | Designation / Role | DIN | Category |
|---|---|---|---|
| Mr. Sanjeev Aggarwal | Chairman & Independent Director | 00006552 | Non-Executive Independent Director |
| Mrs. Sonal Agarwal | Independent Director | 08212478 | Non-Executive Independent Director |
| Mr. Shailendra Sinha | Managing Director | 08649186 | Executive Director (KMP) |
| Mr. Rathi Binod Pal | Director | 00092049 | Non-Executive Non-Independent Director |
| Mr. Sanjiv Kumar Agarwal | Director | 01623575 | Non-Executive Non-Independent Director |
| Mr. Vinod Kumar Gupta | Director | 00006526 | Non-Executive Non-Independent Director |
| Mr. Naveen Chandra Barthwal | Chief Financial Officer | Not Applicable | Key Managerial Personnel (CFO) |
| Mr. Suresh Kumar | Company Secretary & Compliance Officer | ACS 41503 | Key Managerial Personnel (CS) |
Who Owns the Stock? Shareholding Pattern
The shareholding structure demonstrates substantial promoter concentration, with 74.55% of outstanding equity shares controlled by promoter and promoter group entities. Public and retail shareholders hold the remaining 25.45% stake.
| Category of Shareholder | Number of Shares (31/03/2026) | % of Total Shares (31/03/2026) | Number of Shares (31/03/2025) | % of Total Shares (31/03/2025) | Latest YoY (%) |
|---|---|---|---|---|---|
| A. Promoter and Promoter Group | |||||
| Individuals / HUF (Mr. Bhavesh Jindal) | 250 | 0.00% | 250 | 0.00% | 0.00% |
| Bodies Corporate (Concatenate Imaging Advest Pvt Ltd) | 74,37,014 | 67.94% | 74,37,014 | 67.94% | 0.00% |
| Bodies Corporate (Consolidated Finvest & Holdings Ltd) | 3,91,018 | 3.57% | 3,91,018 | 3.57% | 0.00% |
| Trusts (Bhavesh Trust & Futuristic Trust) | 3,31,989 | 3.03% | 3,31,989 | 3.03% | 0.00% |
| Total Promoter Holding | 81,60,271 | 74.55% | 81,60,271 | 74.55% | 0.00% |
| B. Public Shareholding | |||||
| Mutual Funds / UTI | 38 | 0.00% | 38 | 0.00% | 0.00% |
| Financial Institutions / Banks | 50 | 0.00% | 50 | 0.00% | 0.00% |
| Bodies Corporate | 3,88,374 | 3.55% | 1,38,956 | 1.27% | +179.49% |
| Individual Shareholders (Nominal Capital up to ₹0.0200 Crores) | 8,11,889 | 7.42% | 11,34,630 | 10.37% | -28.44% |
| Individual Shareholders (Nominal Capital in excess of ₹0.0200 Crores) | 13,42,858 | 12.27% | 12,41,388 | 11.34% | +8.17% |
| Non-Resident Indians (NRIs) | 1,61,109 | 1.47% | 1,68,553 | 1.54% | -4.42% |
| Hindu Undivided Families (HUFs) | 55,538 | 0.51% | 76,241 | 0.70% | -27.15% |
| Investor Education and Protection Fund (IEPF) | 26,262 | 0.24% | 26,262 | 0.24% | 0.00% |
| Trusts (Public) | 215 | 0.00% | 215 | 0.00% | 0.00% |
| Total Public Shareholding | 27,86,333 | 25.45% | 27,86,333 | 25.45% | 0.00% |
| Grand Total (A + B) | 1,09,46,604 | 100.00% | 1,09,46,604 | 100.00% | 0.00% |
🗺️ The Corporate Family Tree: Group Structure & Strategic Investments
Subsidiaries, Associates, & Joint Ventures (Form AOC-1)
The company maintains no direct subsidiaries. Operations outside its primary domestic conversion umbrella are channeled exclusively through a 39.87% ownership stake in its Netherlands-incorporated associate company, JPF Netherlands B.V., which controls international packaging substrates and specialty film platforms across Europe and North America.
| Entity Name | Relationship | Country of Incorporation | % Equity Stake | Reported Turnover (Associate FY 25-26) | Profit / (Loss) Considered in Consolidation (₹ in Crores) |
|---|---|---|---|---|---|
| JPF Netherlands B.V. | Associate Company | Netherlands | 39.87% | – | (99.20) |
During FY 2025-26, the company subscribed to a rights issue announced by JPF Netherlands B.V., purchasing 39,86,968 Class A shares at a subscription price of Euro 3.00 per share, representing an aggregate cash investment of ₹1.25 Crores (₹1.25 Crore). The total equity holding reached 1,80,69,896 shares as of March 31, 2026, with an adjusted equity-accounted carrying value of ₹5.44 Crores on the consolidated balance sheet.
Strategic Investments & Treasury Holdings
Universus holds significant current liquidity allocated across short-term debt and corporate bond mutual funds. As of March 31, 2026, the fair value of these liquid investments stood at ₹2.73 Crores (₹2.73 Crore), generating net realized gains of ₹23.55 Crores and net mark-to-market adjustments of ₹(456.52) in Crores during the fiscal year.
| Mutual Fund Portfolio Scheme | Units Held (31/03/2026) | Fair Value as on 31/03/2026 (₹ in Crores) | Units Held (31/03/2025) | Fair Value as on 31/03/2025 (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|---|---|
| Axis Bank Corporate Debt Fund | 3,54,084.62 | 66.42 | 3,54,084.62 | 62.41 | 0.00% |
| SBI Corporate Bond Fund – Direct Growth | 2,91,891.87 | 48.18 | 2,95,995.78 | 46.19 | -1.39% |
| ICICI Prudential Banking and PSU Debt Fund | 1,35,632.77 | 47.95 | 1,35,632.77 | 45.27 | 0.00% |
| ABSL Corporate Bond Fund | 36,872.20 | 43.48 | 34,796.21 | 39.13 | +5.97% |
| ICICI Prudential Corporate Bond Fund | 83,082.75 | 26.97 | 2,41,303.54 | 73.72 | -65.57% |
| Axis Bank Short Term Growth | 57,050.25 | 20.03 | 57,050.25 | 18.77 | 0.00% |
| DSP Mutual Funds Short Term Direct Growth | 24,706.78 | 12.99 | 24,706.78 | 12.21 | 0.00% |
| DSP Corporate Bond Fund – Direct Growth | 19,721.76 | 3.34 | 19,721.76 | 3.13 | 0.00% |
| HDFC Corporate Bond Fund – Direct Growth | 5,291.63 | 1.81 | 2,23,324.62 | 72.67 | -97.63% |
| UTI Short Term Income Fund – Growth | 2,276.31 | 0.80 | 2,276.31 | 0.75 | 0.00% |
| SBI Short Term Debt Fund – Direct Growth | 2,150.42 | 0.76 | 2,150.42 | 0.72 | 0.00% |
| Total Current Mutual Fund Portfolio | 9,06,930.71 | 272.71 | 14,35,846.57 | 376.83 | -36.84% |
🎯 The Strategic Outlook: Competitive Moats, Risks & Future Growth Plans
Competitive Advantages & Economic Moats
- Institutional Heritage & Infrastructure: Access to B.C. Jindal Group’s engineering and manufacturing capabilities enables lean plant conversion economics, slitting precision, and high operational discipline relative to standalone converters.
- Debt-Free Balance Sheet: The company operates with zero long-term borrowings and zero short-term bank borrowings, allowing management to navigate operational sector slowdowns without capital distress.
- Significant Liquid Treasury Buffer: Holding ₹2.73 Crores in high-grade debt mutual funds provides substantial liquidity to fund potential business model transitions or health-tech diversification.
- Established Distribution in Analog Niches: Sustained vendor relationships with government tender boards, civil medical departments, and rural clinics preserve high entry barriers against new entrants in a declining analog market.
What Could Go Wrong? Key Challenges & Business Risks
The company confronts fundamental structural challenges within its core operational product segment:
- Digitalization of Diagnostic Imaging: The rapid expansion of computed radiography (CR), direct digital radiography (DR), CT scans, and picture archiving and communication systems (PACS) continues to shrink the market for wet X-ray films. The domestic market of ~10 Lakh sq. mt. remains under secular contraction.
- Associate Company Volatility: Substantial equity accounting losses from JPF Netherlands B.V. (₹99.20 Crores share in associate losses during FY 2025-26) represent a significant drag on consolidated profitability.
- Raw Material & Foreign Exchange Dependency: Total raw materials consumed (₹9.81 Crores) are 100% imported master rolls. Any severe depreciation of the Indian Rupee directly elevates conversion costs.
The Next Chapter: Growth, Order Pipeline & CapEx Initiatives
Management’s strategic vision involves extracting residual value from conventional medical X-ray films while actively evaluating adjacent business lines across healthcare consumables, diagnostics, and specialty packaging substrates. The company has proposed entering into material related-party transactions for the purchase of flexible poly films from JPFL Films Private Limited up to an aggregate cap of ₹50 Crore over three financial years (FY 2026-27 to FY 2028-29). This initiative aims to utilize existing conversion, slitting, and sales distribution channels to enhance capacity utilization and operational scale.
The Verdict: Strategic Outlook & Conclusion
Universus Photo Imagings Limited presents an uncommon corporate profile: an operational conversion business facing structural decline in conventional radiology, counterbalanced by a pristine, debt-free domestic balance sheet and ₹2.73 Crore in liquid treasury mutual funds. While equity accounting exposure to JPF Netherlands B.V. induces significant volatility in consolidated earnings, the parent company’s operational discipline, complete lack of debt leverage, and substantial treasury reserves provide strategic flexibility as management explores adjacent sectors in healthcare and value-added films.
Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.
Official Site: https://www.universusphotoimagings.com